XML 35 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
SEGMENT REPORTING
(16) SEGMENT REPORTING
 
The Company has one reporting segment, the Electrotherapy and Pain Management segment, which includes the ZMI electrotherapy units and compound pain creams operations that accounted for 99% and 99% of total net revenue for the year ended December 31, 2016 and 2015, respectively. The determination was made based on the fact that the products are marketed through the same sales representatives and to the same medical providers whether the provider writes a prescription for an electrotherapy device or compound pain cream. The revenue generated from the sale of other products and services is not significant.